A Novel CREBBP Mutation and Its Phenotype in a Case of Rubinstein-Taybi Syndrome

Overview

Journal BMC Med Genomics

Publisher Biomed Central

Specialty Genetics

Date 2022 Aug 19

PMID 35986282

Authors

Qian Wang

Cong Wang

Wen Bin Wei

Wei Ning Rong

Xiang Yu Shi

Affiliations

Soon will be listed here.

Abstract

Background: This study was to report a novel CREBBP mutation and phenotype in a child with Rubinstein-Taybi syndrome.

Methods: Case report of a 9-year-old boy.

Results: We described the patient's clinical manifestations in detail, and found that in addition to the typical systemic manifestations of the syndrome, the outstanding manifestation of the child was severe intellectual deficiency and prominent ocular abnormalities. Whole-exome sequencing and sanger sequencing were performed on the patient and his parents, a large intragenic deletion, covering the exon 1 region and part of the intron 1 region of the TRAP1 gene, and the entire region from intron 27 to exon 30 of the CREBBP gene (chr16:3745393-3783894) was identified on the patient. This mutation affected the CREBBP histone acetyltransferase (HAT) domain.

Conclusions: This findings in our patient add to the spectrum of genetic variants described in Rubinstein-Taybi syndrome and present a RSTS patient with various ocular anomalies including early onset glaucoma.

Citing Articles

Differential microRNA expression in the SH-SY5Y human cell model as potential biomarkers for Huntington's disease.

Belkozhayev A, Niyazova R, Kamal M, Ivashchenko A, Sharipov K, Wilson C Front Cell Neurosci. 2024; 18:1399742.

PMID: 39049823 PMC: 11267620. DOI: 10.3389/fncel.2024.1399742.

De novo variation in EP300 gene cause Rubinstein-Taybi syndrome 2 in a Chinese family with severe early-onset high myopia.

Huang X, Rui X, Zhang S, Qi X, Rong W, Sheng X BMC Med Genomics. 2023; 16(1):84.

PMID: 37085840 PMC: 10120144. DOI: 10.1186/s12920-023-01516-9.

References

Schoof M, Launspach M, Holdhof D, Nguyen L, Engel V, Filser S . The transcriptional coactivator and histone acetyltransferase CBP regulates neural precursor cell development and migration. Acta Neuropathol Commun. 2019; 7(1):199. PMC: 6896766. DOI: 10.1186/s40478-019-0849-5. View

Elalaoui S, Smaili W, Van-Gils J, Fergelot P, Ratbi I, Tajir M . Clinical description and mutational profile of a Moroccan series of patients with Rubinstein Taybi syndrome. Afr Health Sci. 2021; 21(2):960-967. PMC: 8568211. DOI: 10.4314/ahs.v21i2.58. View

Perez-Grijalba V, Garcia-Oguiza A, Lopez M, Armstrong J, Garcia-Minaur S, Mesa-Latorre J . New insights into genetic variant spectrum and genotype-phenotype correlations of Rubinstein-Taybi syndrome in 39 CREBBP-positive patients. Mol Genet Genomic Med. 2019; 7(11):e972. PMC: 6825870. DOI: 10.1002/mgg3.972. View

Bentivegna A, Milani D, Gervasini C, Castronovo P, Mottadelli F, Manzini S . Rubinstein-Taybi Syndrome: spectrum of CREBBP mutations in Italian patients. BMC Med Genet. 2006; 7:77. PMC: 1626071. DOI: 10.1186/1471-2350-7-77. View

Hennekam R . Rubinstein-Taybi syndrome. Eur J Hum Genet. 2006; 14(9):981-5. DOI: 10.1038/sj.ejhg.5201594. View

Rusconi D, Negri G, Colapietro P, Picinelli C, Milani D, Spena S . Characterization of 14 novel deletions underlying Rubinstein-Taybi syndrome: an update of the CREBBP deletion repertoire. Hum Genet. 2015; 134(6):613-26. DOI: 10.1007/s00439-015-1542-9. View

Spena S, Gervasini C, Milani D . Ultra-Rare Syndromes: The Example of Rubinstein-Taybi Syndrome. J Pediatr Genet. 2016; 4(3):177-86. PMC: 4918723. DOI: 10.1055/s-0035-1564571. View

Lee J, Byun C, Kim H, Lim B, Hwang H, Choi J . Clinical and mutational spectrum in Korean patients with Rubinstein-Taybi syndrome: the spectrum of brain MRI abnormalities. Brain Dev. 2014; 37(4):402-8. DOI: 10.1016/j.braindev.2014.07.007. View

van Genderen M, Kinds G, Riemslag F, Hennekam R . Ocular features in Rubinstein-Taybi syndrome: investigation of 24 patients and review of the literature. Br J Ophthalmol. 2000; 84(10):1177-84. PMC: 1723270. DOI: 10.1136/bjo.84.10.1177. View

10.

Chen C, Chen Y, Dai K, Chen P, Riley D, Lee W . A new member of the hsp90 family of molecular chaperones interacts with the retinoblastoma protein during mitosis and after heat shock. Mol Cell Biol. 1996; 16(9):4691-9. PMC: 231469. DOI: 10.1128/MCB.16.9.4691. View

11.

Stef M, Simon D, Mardirossian B, Delrue M, Burgelin I, Hubert C . Spectrum of CREBBP gene dosage anomalies in Rubinstein-Taybi syndrome patients. Eur J Hum Genet. 2007; 15(8):843-7. DOI: 10.1038/sj.ejhg.5201847. View

12.

Petrij F, Giles R, Dauwerse H, Saris J, Hennekam R, Masuno M . Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature. 1995; 376(6538):348-51. DOI: 10.1038/376348a0. View

13.

Fergelot P, Van Belzen M, Van Gils J, Afenjar A, Armour C, Arveiler B . Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. Am J Med Genet A. 2016; 170(12):3069-3082. DOI: 10.1002/ajmg.a.37940. View

14.

Felts S, Owen B, Nguyen P, Trepel J, Donner D, Toft D . The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. J Biol Chem. 2000; 275(5):3305-12. DOI: 10.1074/jbc.275.5.3305. View

15.

Choi N, Kim H, Lim B, Chae J, Kim S, Ko J . Genetic and clinical heterogeneity in Korean patients with Rubinstein-Taybi syndrome. Mol Genet Genomic Med. 2021; 9(10):e1791. PMC: 8580098. DOI: 10.1002/mgg3.1791. View

16.

Hutchinson D, Sullivan R . Rubinstein-Taybi Syndrome. J Hand Surg Am. 2015; 40(8):1711-2. DOI: 10.1016/j.jhsa.2014.08.043. View

17.

Bartsch O, Schmidt S, Richter M, Morlot S, Seemanova E, Wiebe G . DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS. Hum Genet. 2005; 117(5):485-93. DOI: 10.1007/s00439-005-1331-y. View

18.

Roelfsema J, White S, Ariyurek Y, Bartholdi D, Niedrist D, Papadia F . Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet. 2005; 76(4):572-80. PMC: 1199295. DOI: 10.1086/429130. View

19.

Yu P, Luk H, Lo I . Rubinstein-Taybi syndrome in Chinese population with four novel mutations. Am J Med Genet A. 2020; 185(1):267-273. DOI: 10.1002/ajmg.a.61922. View

20.

Lopez M, Garcia-Oguiza A, Armstrong J, Garcia-Cobaleda I, Garcia-Minaur S, Santos-Simarro F . Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum. BMC Med Genet. 2018; 19(1):36. PMC: 5839060. DOI: 10.1186/s12881-018-0548-2. View